Investigational drugs for treating major depressive disorder
Author:
Affiliation:
1. Department of Neurology, School of Medicine, University of California Davis, Sacramento, CA, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1267727
Reference101 articles.
1. A 30-Year Study of 3 Generations at High Risk and Low Risk for Depression
2. Mortality rates in major and subthreshold depression: 10-year follow-up of a Singaporean population cohort of older adults
3. Impaired Frontal-Limbic White Matter Maturation in Children at Risk for Major Depression
4. Comparing how co-morbid depression affects individual domains of functioning and life satisfaction in schizophrenia
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Potential of Fingolimod on Psychological Symptoms and Cognitive Function in Neuropsychiatric and Neurological Disorders;Neurochemical Research;2024-06-26
2. The Structure-property Relationships of GPCR-targeted Drugs Approved between 2011 and 2021;Current Medicinal Chemistry;2023-09
3. Machine-learning repurposing of DrugBank compounds for opioid use disorder;Computers in Biology and Medicine;2023-06
4. Congenital anomalies and spontaneous abortion in mice resulting from the use of escitalopram;Reproduction, Fertility and Development;2022-10-12
5. The Glutamatergic System as a Target for the Development of New Pharmacological Treatments of Bipolar Disorder;Glutamate and Neuropsychiatric Disorders;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3